Managing Multiple Sclerosis Care During COVID-19

Mark Gudesblatt, MD, Carlo Tornatore, MD, and Cary Twyman, MD, discuss how to care for patients with multiple sclerosis in a world changed by COVID-19. They outline approaches to monitor disease status while balancing infection risk, immunodeficiency, and disability. And they explain how the experiences gleaned from the pandemic could reshape the care of MS for the better.

Monitoring disease impact with limited direct contact

In the first segment of the roundtable, Dr. Gudesblatt, Dr. Tornatore, and Dr. Twyman discuss how to effectively monitor disease impact and disability remotely, and they focus on which metrics matter most in a time of telehealth.

Up Next

Monitoring disease impact with limited direct contact
How to manage medications and treatment
Overcoming the challenges of shared decision-making
How the pandemic will reshape multiple sclerosis care

About the Panel

Mark Gudesblatt, MD

  • Medical Director,
  • South Shore Neurologic Associates

Carlo Tornatore, MD

  • Professor and Chairman,
  • Georgetown University Medical Center

Cary Twyman, MD

  • Assistant Clinical Professor of Neurology,
  • Penn State Health MSH Medical Center

The faculty received modest honoraria from Frontline Medical Communications for their participation in this roundtable.

Dr. Gudesblatt has nothing to disclose.

Dr. Tornatore has served as a speaker and advisory board member for Biogen, Genentech, Serono, and Sanofi. He has received research grants from Biogen, Genentech.

Dr. Twyman reports receiving consulting fees, honoraria, travel, and research support from Alexion, Biogen Idec, Celgene, Genentech, Genzyme, NMSS, Novartis, Serono, and TG Therapeutics.